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MAO (monoamine oxidase) is an enzymatic system 
that comprises two isoenzymes: MAO-A and MAO-B, 
with more than 70% identity in their amino acid 
sequence1. The prominent role of MAO-A and MAO-
B is the oxidation of aliphatic and aromatic amines to 
the corresponding aldehydes. The inhibition of the 
latter is implemented in two substantial 
neurodegenerative diseases – Alzheimer’s and 
Parkinson’s diseases2.  
Administration of MAO-B inhibitors in treating the 
latter disorders has shown promising results in early 
and advanced stages of the conditions, considering the 
conservation of high dopamine levels in the synaptic 
cleft. Hence, both endogenous and exogenously 
administered dopamine concentrations could be 
retained after treatment with selective MAO-B 
inhibitors, and the effects are manifested3. Moreover, 
all monoamine oxidase inhibitors demonstrate 
additional neuroprotective effects arising from 
decreased neuronal toxic radicals and peroxides4. 
A significant breakthrough in the design and the 
optimization of novel MAO-B inhibitors has been 
made after the first resolved crystallographic MAO-B 
structure5. The study revealed three distinct domains 
in the active site of the receptor – entrance pocket, 
substrate cavity, and aromatic cage. It has also been 
postulated that the major ligand interactions in the 
binding gorge are the hydrophobic ones6. Moreover, 
four amino residues: Tyr-326, Leu-171, Ili-199, and 
Phe-168, are reported to act like a “gate” between the 
entrance and the substrate cavities. For an additional 
stabilization in the ligand-receptor complex, hydrogen 
bonds with Tyr-3987, Gln-2068, and FAD9 have been 
described. 
Ever since the computer-aided drug design (CADD) 
simulations were introduced in the drug discovery 
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Recently, the application of molecular docking is drastically increasing 
due to the rapid growth of resolved crystallographic receptors with co-
crystallized ligands. However, the inability of docking softwares to 
correctly score the occurred interactions between ligands and 
receptors is still a relevant issue. This study examined the Pearson’s 
correlation coefficient between the experimental monoamine oxidase-
B (MAO-B) inhibitory activity of 44 novel coumarins and the obtained 
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ensemble docking simulations into two superimposed complexes 
were performed. The model was validated with a test set. A significant 
Pearson’s correlation coefficient of 0.8217 was obtained for the latter. 
In the final stage of our work, we observed the major interactions 
between the top-scored ligands and the active site of 1S3B. 
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processes, the time required to develop and optimize 
new molecules was drastically reduced10. Molecular 
docking is one of the most utilized structure-based 
drug design (SBDD) techniques as it is emerging as 
frequently applied in the optimization step of active 
ligands. Furthermore, it could be utilized for the 
virtual screenings of novel and effective drug 
candidates11,12. However, several challenges regarding 
the accuracy of molecular docking are still to be 
resolved. The major issues are related to the estimative 
character of the scoring functions13 and the inefficiency 
of the fully flexible simulations14.  
In order to acquire reliable docking results, the 
molecular docking protocol should be validated. 
Several validation methods such as re-docking, cross-
docking, high enrichment factors, and enhanced 
correlation coefficients between experimental affinities 
and docking scores have been described15. The latest 
technique is often used to evaluate the correctness of 
the scoring function and the search algorithm through 
a created relationship with the experimentally 
acquired data. The correlation coefficients can vary 
considering the applied chemical dataset and the 
characteristics of the receptor16. However, an 
optimization of the docking protocol after altering the 
size of the binding pocket, the utilized scoring 
function, the flexibility of the side chain residues, and 
the presence of active waters often lead to superior 
correlation values17.  
This study aimed to examine the effects of various 
docking protocols on Pearson’s correlation coefficient 
of a coumarins dataset. All docking settings included 
in GOLD 5.3 were incorporated in the optimization 
process with further correlation coefficient 
calculations at each stage. Moreover, the significant 
intermolecular interactions between the top-scored 
ligands and the active site of 1S3B were examined. 
 
METHOD 
Hardware and Software 
The docking simulations were carried out on an AMD 
Ryzen 5 3600 6-core 3.6GHz CPU, GeForce GTX 1060 
3 GB GPU, 16 GB RAM installed memory, 64-bit 
Operating system on Windows 10 Pro. GOLD 5.3 
(Genetic Optimization for Ligand Docking) from The 
Cambridge Crystallographic Data Centre 
(https://www.ccdc.cam.ac.uk/solutions/csd-
discovery/Components/gold/)18 was used for the 
current docking simulations. It comprises four scoring 
algorithms: ChemPLP, GoldScore, ASP, and 
ChemScore. GoldScore considers mainly Van der 
Waals interactions and hydrogen bonds. ChemScore is 
the empirical algorithm of GOLD which was 
calibrated from numerous complexes with known 
binding affinities. ASP represents the knowledge-
based function, while ChemPLP used piecewise linear 
potential to score the contacts in the ligand-receptor 
complex19. 
In this study, all the latest scoring functions were 
utilized to evaluate the most prominent one for the 
current dataset. For the pre-docking procedures, the 
docking visualizer Hermes18 was applied. The 
preparation of the ligands and the receptors were 
conducted in Hermes as well as ChemDraw and 
Chem3D from Perkin Elmer Informatics 
(http://www.cambridgesoft.com/support/Product
HomePage.aspx?KBCatID=112). The statistical 
calculations were performed in the JMP® Pro 12 from 
SAS Institute Inc. 
(https://www.jmp.com/en_us/home.html). The 
major interactions between the top-scored ligands and 
the active site of MAO-B receptor were visualized 
using Discovery Studio Visualizer from BIOVIA 





Forty-four substituted coumarin derivatives were 
taken from a published paper by Pisani et al7. The 
ligands were grouped into two sets: a training and a 
test set. In the training set, we situated 35 compounds, 
while for the validation of the model, we applied nine 
structures. All coumarin derivatives used in our study 
were given in Table I with the corresponding pIC50 
values. 
The drawing of the ligands and the conversion into the 
corresponding 3D structures were conducted in 
ChemDraw and Chem3D, respectively. The energy 
minimization procedures were also carried out in 
Chem3D with an early termination set at 2000 
iterations and minimum root mean square (RMS) 
gradient fixed at 0.01000. During the docking 
simulations, the rotations of the ligands were set to 
“flexible”. 
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Compound R1 R2 pIC50 
1 Cl Et 7.54 
2 Cl Me 6.06 
3 Cl CH2Cl 7.33 
4 Br CH2Cl 6.38 
5 Br OH 6.31 
6 Cl CHO 7.28 
7 Cl COOEt 6.38 
8 Cl CONH2 6.63 
9 Cl CN 6.99 
10 Cl CH(OH)CH3 7.11 
11 Cl CH2CN 7.80 
12 Cl CH2CONHMe 7.62 
13 Cl CH2CON(Me)2 7.4 
14 Cl CH2NHMe 7.89 
15 Cl CH2N(Me)2 5.95 
16 Cl CH2-4`-morpholinyl 5.64 
17 H OMe 7.00 
18 F OMe 7.44 
19 H OEt 6.12 
20 F OEt 6.58 
21 Cl OEt 6.94 
22 Br OEt 6.9 
23 Cl OnPr 7.21 
24 Br OnPr 7.13 
25 Cl OCH2OMe 7.00 
26 Cl NHEt 7.55 
27 Cl NHCOOMe 7.41 
28 Cl NHCOOEt 6.23 
29 Br OCH2CONH2 80.08 
30 Cl OCH2CONHMe 7.47 
31 Cl (CH2)2OH 8.13 
32 Cl (CH2)2Cl 7.89 
33 Cl (CH2)2Br 7.49 
34 Cl (CH2)2CONH2 7.82 
35 CL (CH2)2CN 7.54 
Test set 
1 Cl OH 6.32 
2 Cl COCH3 7.40 
3 Cl CHNOH 6.66 
4 Cl CH2CONH2 7.52 
5 H OnPr 6.24 
6 Cl OCH2CON(Me)2 6.30 
7 Cl OCH2COCH3 7.57 
8 Cl NHCH2CONH2 7.31 




Receptors with Protein Data Bank (PDB) IDs 1OJA, 
1OJC20, 1S3B21, and 2V6022 were retrieved from Protein 
Data Bank (https://www.rcsb.org) with resolutions 
under 2 Å23. Monomer B from all receptors was 
removed with the co-crystallized ligands and the co-
factors lying in the corresponding monomer. In the 
case of present covalent bonds between the co-
crystallized ligands and the co-factors, they were 
removed. 
Docking protocol 
The GOLD wizard setup was utilized for rapid 
extraction of co-crystallized ligands and waters. 
Additional hydrogen bonds were added with the help 
of the former wizard. The search efficiency was set at 
100% (default setting) with no early termination. 
During all dockings, the ligands were set to flexible, 
and initial energy minimization was carried out. 
The starting docking protocol was built out of 
ChemPLP as a scoring function, 6 Å binding grid, no 
protein flexibility, and no active waters. All default 
parameters were altered to obtain a higher correlation 
coefficient between the experimental data and the 
obtained fitness scores. Primarily, the scoring 
functions and the size of the binding space were 
varied. The scoring algorithm was chosen based on the 
lowest R2 value and the shortest simulation time. 
Analysis regarding the presence of active water 
molecules was performed, which examinations with 
and without waters in the active sites were conducted. 
After each simulation, the Person’s correlation 
coefficient was calculated. After that, ten amino acids 
(Thr-195, Ile-198, Ile-199, Tyr-326, Phe-343, Leu-345, 
Tyr-398, Thr-399, Tyr-435, and Met-436) located in the 
binding cleft were set to flexible to examine the shift in 
the correlation coefficient. Finally, an ensemble 
docking was conducted after the superimposition of 
1S3B-2V60 and 1OJA-1OJC-1S3B receptor structures. 
The latter complex demonstrated the highest MAO-B 
enrichment in one of our recent researches (to be 
published) and thus was examined in the current 
work. 
 
RESULTS AND DISCUSSION 
Re-docking 
Re-docking procedures were carried out to assess the 
ability of the docking software to correctly place the co-
crystallized ligands back into the binding pocket of the 
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receptors24. The reliability of GOLD 5.3 to correctly 
place the co-crystallized ligands of 1OJA, 1OJC, 1S3B, 
and 2V60 was unambiguous. The root-mean-square 
deviation (RMSD) for all receptors was under 2 Å, as 
shown in Table II. 
Table II. RMSD values of the re-docked co-crystallized 
ligands of 1OJA, 1OJC, 1S3B and 2V60 
PDB Co-crystallized ligand 
RMSD 
(Å) 
1OJA Isatin 1.18 








Optimizations of the docking protocol 
All four scoring algorithms were applied to evaluate 
which was the most prominent one for the current 
dataset25. The rest of the docking settings were set to 
default. After each docking simulation, Pearson’s 
correlation coefficient was calculated. ChemPLP had 
displayed the ability to acquire the highest correlation 
value, and the former scoring function was employed 
in the forthcoming protocols, as shown in Table III. 
Interestingly, GoldScore, ChemScore, and ASP 
showed significantly lowered accuracy when they 
were utilized to score the current dataset. GoldScore 
could not correctly score compound 16, which led to a 
significantly lowered Pairwise correlation coefficient 
of 0.2802. Moreover, when ASP was used, there was 
no correlation at all – R2= 0.0876. The scoring function 
with the fastest run time was ChemPLP, while 
GoldScore demonstrated the longest simulation 
periods (double the time of ChemPLP). Considering 
the lengthy docking times, together with the 
unacceptable correlation coefficients obtained with 
GoldScore, ChemScore, and ASP, further studies with 
the latter GOLD 5.3 scoring algorithms were not 
conducted. 













0.5138 35 0.2178 0.7232 0.0016 
pIC50 GoldScore 
6 Å 
0.2802 35  -0.0585 0.5611 0.1030 
pIC50 Chemscore 
6 Å 
0.3535 35 0.0229 0.6143 0.0373 
pIC50 ASP 6 Å 0.0876 35  -0.2531 0.4089 0.6169 
 
Subsequently, the size of the binding gorge was 
modified to 8, 10, and 12 Å, when ChemPLP was used 
as a scoring function. Overall, when the size of the grid 
box was expanded, the correlation coefficients 
increased26. The highest value (R2= 0.5929) was 
obtained when the grid size was set to 12 Å. For the 
magnitude of the applied dataset, the run times were 
relatively similar, with a slight increase after each 
expansion of the grid space. The results were 
presented in Table IV. 
Table IV. Calculated correlation coefficient after alterations 
in the size of the binding gorge 
Scoring 
Algorithm 
Grid size (Å) 
Pearson’s correlation 
coefficient 





Optimization of the docking protocol was proceeded 
by altering the presence of water molecules in the 
active site27. Eight active water molecules (HOH-612, 
HOH-617, HOH-621, HOH-631, HOH-671, HOH-818, 
HOH-871, and HOH-883) were extracted and utilized 
for subsequent docking simulations. The calculated R2 
value, when the waters were taken into consideration, 
was given in Table V. A drastic drop in the correlation 
coefficient was observed after the employment of 
active waters. In addition, the inability of the docking 
software to correctly score compound 34 was noticed. 
The former ligand received a false-positive fitness 
score of 121; thus, the correlation coefficient was 
calculated to be 0.4603. No further examinations with 
active waters were conducted considering the latter 
observations. It is important to note that in most cases, 
the active water molecules play an essential role in 
forming a stable complex28. However, in this work, the 
number of falsely scored results significantly increased 
when eight water molecules were included in the 
binding site. 
Table V. Pairwise correlation coefficient after docking 
simulations with active waters 
Variable 
1 












0.4603 35 0.1501 0.6880 0.0054 
 
During the last optimization step, we considered the 
flexibility of the side chain residues. Ten amino acids: 
Thr-195, Ile-198, Ile-199, Tyr-326, Phe-343, Leu-345, 
Tyr-398, Thr-399, Tyr-435, and Met-436, located in the 
active site, were set to a freely flexible state during the 
docking simulations. It was noted that the R2 value 
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dropped significantly from 0.5829 to 0.2921. The latter 
observation disposes a concern into the positive effect 
of flexible side chains in the reliable representations 
and scoring of the occurring MAO-B/coumarins 
intermolecular interactions. Furthermore, papers 
discussing higher enrichment values after semi-
flexible receptor docking were reported29,30, which 
contrasted with this work. 
In addition to the unsatisfactory results obtained from 
the side chain flexible dockings, the ensemble docking 
simulations of the described coumarins into two 
superimposed complexes: 1S3B-2V60 and 1OJA-
1OJC-1S3B was examined. The receptor 2V60 was 
used owing to the chemical similarity between the co-
crystallized ligand and the utilized in this study 
dataset. At the same time, the second superimposed 
complex demonstrated the highest enrichment value 
in a recently conducted study (to be published). 
Correlation coefficients of 0.4238 and 0.4508 were 
obtained, as shown in Table VI. However, the 
described technique was not applicable for a future 
virtual screening due to lower Pairwise correlation 
coefficients than the protocol mentioned earlier. 











pIC50 1S3B-2V60 0.4238 35 0.1054 0.6634 0.0112 
pIC50 1OJA-
1OJC-1S3B 
0.4508 35 0.2134 0.6951 0.0093 
 
Overall, the most prominent GOLD 5.3 docking 
protocol of novel MAO-B inhibitors with coumarin 
moiety was composed of the scoring function 
ChemPLP, size of the binding site 12 Å, absence of 
active waters, and no partial protein flexibility. 
Furthermore, the utilization of ensemble docking did 
not achieve any enhancements in the correlation value.  
In order to validate the docking protocol, a test set built 
of nine chemically similar to the training set ligands, 
with a wide range of experimentally acquired binding 
affinities, was applied. The calculated Pearson’s 
correlation coefficient of the test set equaled 0.8217, as 
shown in Table VII. The latter value was statically 
significant; thus, the model could be applied for a 
future virtual screening of novel MAO-B inhibitors. 













pIC50 Test set 0.8217 9 0.3470 0.9613 0.0066 
 
Visualizations of the major interactions 
Two of the top-scored compounds located in the 
training set were visualized their major interactions 
with the active site of 1S3B. Both the 2D and 3D 
interaction diagrams of compounds 29 and 34 were 
provided in Figures 1 and 2, respectively. As 
demonstrated below, the poses of both ligands in the 
active site of MAO-B were exceptionally similar. The 
amide group in both cases was sandwiched in the 
aromatic cage, and a strong hydrogen bond was 
formed with FAD600. The core structure of coumarin 
was located in the substrate pocket, where it was 
stabilized by Van der Waals and hydrophobic 
interactions. The latter weak forces also occurred 
between the p-substituted phenyl moiety and the 
entrance cavity of the receptor. The absence of a 
delocalized cyclic system in the aromatic cage led to -
 stacking interactions between the benzene ring31 and 
the amino residue Tyr-326. A -sulfur bond between 
Cys-172 and the coumarin's phenyl group in 
compound 29 was the only deviation in the interaction 
pattern between the two ligands. 
  
A     B 
Figure 1. (A) 2D and (B) 3D diagrams of the major occurring interactions between 1S3B and the compound 29. 
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A     B 
Figure 2. (A) 2D and (B) 3D diagrams of the major occurring interactions between 1S3B and the compound 34. 
 
All the docking fitness scores and the major amino 
residues that participate in stabilizing the ligand-
receptor complexes in the test set are given in Table 
VIII. As discussed before, nine ligands were included 
in the test set, and an R2 value of 0.8217 was achieved. 
Thus, all of the analyzed docking poses should be close 
to the actual poses of the ligands in the active site of 
MAO-B. Compound 4 displayed the highest fitness 
score of 92.11. The complex was stabilized with a 
hydrogen bond between FAD600 and the amide 
group. Moreover, a weaker carbon-hydrogen bond 
was present between Cys-172 and the pyran ring. 
Compound 1 showed the lowest score of 76.93, which 
was plausible considering the low number of 
stabilizing bonds. 
Table VIII. Fitness scores and major interacting amino acid 




Interacting amino acid residues 
1 76.93 Cys-172, Ile-199 Ile-198, Leu-171, 
Leu-164, Trp-119 
2 85.00 Tyr-326, Ile-199, Cys-172, Leu-
171, Ile-198, Trp-119, Leu-164, 
Leu-167 
3 80.07 FAD600, Tyr-326, Ile-199, Cys-
172, Ile-198, Leu-171, Leu-164 
4 92.11 FAD600, Cys-172, Tyr-326, Ile-
199, Leu-171, Ile-198, Leu-167, 
Leu-164, 
5 83.46 Tyr-326, Cys-172, Tyr-398, Ile-198, 
Ile-199, Leu-164, Ile-316 
6 83.00 FAD600, Tyr-326, Ile-199, Trp-
119, Leu-164, Leu-171, Ile-198 
7 90.13 FAD600, Tyr-188, Phe-168, Cys-
172, Tyr-326, Ile-199, Ile-198, Leu-
164, Trp-119, Phe-103 
8 86.29 Tyr-326, Cys-172, Pro-104, Ile-199, 
Ile-198, Leu-164, Phe-103, Leu-
171, Leu-163 
9 79.63 Tyr-326, Phe-168, Cys-172, Ile-
199, Ile-198, Pro-104, Phe-103 
 
CONCLUSION 
Good correlation coefficients were achieved in this 
work between the pIC50 values of 44 coumarins 
derivatives with MAO-B activity and their fitness 
scores applying the docking software GOLD 5.3. After 
optimizing the docking protocol for scoring functions, 
grid spaces, and rotatable side residues, a pairwise 
correlation of 0.5929 for the training set and 0.8217 for 
the test set was obtained. The presence of active waters 
and the inclusion of partial protein flexibility that was 
examined did not lead to enhanced correlation 
coefficients. In addition, compounds 29 and 34 
demonstrated strongly identical poses in the active site 
of 1S3B. Overall, a statistically significant Pearson’s 
correlation coefficient was obtained between 
coumarins derivatives and ChemPLP docking scores 
– R2= 0.5929. This finding could be beneficial for future 
virtual screenings in search of novel MAO-B 
inhibitors. 
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